FABRX LTD.

Company Snapshot

Founded: 2014
Entity Type: Private
Region: U.K.
Headquarter: England, U.K.
Key Geographics: U.K., Spain, U.S.
Corporate Address: Henwood House, Henwood, Ashford, Kent, England, TN24 8DH, U.K. Tel.: +44-20-3286-0000 Web.: www.fabrx.co.uk

Company Overview

FABRX Ltd is a pharmaceutical technology company specializing in 3D printing solutions for the development and manufacture of personalized medicines. It offers advanced 3D printing systems, software, and formulation platforms designed for research, clinical, and point-of-care applications, enabling dose customization and flexible drug delivery.

FABRX LTD. In Reports

Global 3D Printing Drugs Market

global 3D printing drugs market, covering pharmaceutical innovation, drug manufacturing trends, technology advances and growth opportunities.

Global Markets for 3D Printing

BCC Research Market Analyst says global market for 3D printing is expected to grow from $18.0 billion in 2024 and is projected to reach $29.4 billion by the end of 2029, at a CAGR of 10.2%.

3D Printing Medical Devices: Global Markets

BCC Research Market Analyst says global market for 3D printing medical devices reached $2.1 billion in 2023 & estimated to grow from $2.2 billion in 2024 to $4.5 billion by the end of 2029.

Company's Business Segments

  • 3D printing : Multi-printhead pharmaceutical 3D printer capable of Rapid Polypill manufacture for Human and Veterinary Precision Medicine and Drug Development.

Applications/End User Industries

  • Human Precision Medicine
  • Veterinary Precision Medicine
  • Drug Development
  • Pharmaceuticals
  • Pressure Sensors
  • Life Sciences
AI Sentiment